These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 23769567)
1. Serum galectin-3: a risk factor for vascular complications in type 2 diabetes mellitus. Jin QH; Lou YF; Li TL; Chen HH; Liu Q; He XJ Chin Med J (Engl); 2013; 126(11):2109-15. PubMed ID: 23769567 [TBL] [Abstract][Full Text] [Related]
2. Association between serum galectin-3 levels and coronary atherosclerosis and plaque burden/structure in patients with type 2 diabetes mellitus. Ozturk D; Celik O; Satilmis S; Aslan S; Erturk M; Cakmak HA; Kalkan AK; Ozyilmaz S; Diker V; Gul M Coron Artery Dis; 2015 Aug; 26(5):396-401. PubMed ID: 25887000 [TBL] [Abstract][Full Text] [Related]
3. Galectin-3 is independently associated with progression of nephropathy in type 2 diabetes mellitus. Tan KCB; Cheung CL; Lee ACH; Lam JKY; Wong Y; Shiu SWM Diabetologia; 2018 May; 61(5):1212-1219. PubMed ID: 29417184 [TBL] [Abstract][Full Text] [Related]
4. Associations between inflammatory markers, traditional risk factors, and complications in patients with type 2 diabetes mellitus. Streja D; Cressey P; Rabkin SW J Diabetes Complications; 2003; 17(3):120-7. PubMed ID: 12738395 [TBL] [Abstract][Full Text] [Related]
5. Relationship between vitamin D status and vascular complications in patients with type 2 diabetes mellitus. Jung CH; Kim KJ; Kim BY; Kim CH; Kang SK; Mok JO Nutr Res; 2016 Feb; 36(2):117-24. PubMed ID: 26826427 [TBL] [Abstract][Full Text] [Related]
6. Association of osteoprotegerin with peripheral artery disease in patients with type 2 diabetes. Esteghamati A; Aflatoonian M; Rad MV; Mazaheri T; Mousavizadeh M; Nakhjavani M; Noshad S Arch Cardiovasc Dis; 2015; 108(8-9):412-9. PubMed ID: 26184866 [TBL] [Abstract][Full Text] [Related]
7. Correlation Analysis between Serum Vitamin D Levels and Lower Extremity Macrovascular Complications in Individuals with Type 2 Diabetes Mellitus. Yang M; Liu J; Zhou X; Ding H; Xu J; Yang B; Sun B; Xiao D; Yu J; Gong Q J Diabetes Res; 2019; 2019():4251829. PubMed ID: 31871946 [TBL] [Abstract][Full Text] [Related]
8. Serum vaspin concentration in elderly patients with type 2 diabetes mellitus and macrovascular complications. Yang W; Li Y; Tian T; Wang L; Lee P; Hua Q BMC Endocr Disord; 2017 Oct; 17(1):67. PubMed ID: 29065866 [TBL] [Abstract][Full Text] [Related]
9. C-reactive protein and risk factors for peripheral vascular disease in subjects with Type 2 diabetes mellitus. Yu HI; Sheu WH; Song YM; Liu HC; Lee WJ; Chen YT Diabet Med; 2004 Apr; 21(4):336-41. PubMed ID: 15049935 [TBL] [Abstract][Full Text] [Related]
10. Baseline High-Sensitivity C-Reactive Protein Predicts Macrovascular and Microvascular Complications of Type 2 Diabetes: A Population-Based Study. Aryan Z; Ghajar A; Faghihi-Kashani S; Afarideh M; Nakhjavani M; Esteghamati A Ann Nutr Metab; 2018; 72(4):287-295. PubMed ID: 29694948 [TBL] [Abstract][Full Text] [Related]
11. Serum asymmetric dimethylarginine and arginine levels predict microvascular and macrovascular complications in type 2 diabetes mellitus. Ganz T; Wainstein J; Gilad S; Limor R; Boaz M; Stern N Diabetes Metab Res Rev; 2017 Feb; 33(2):. PubMed ID: 27393712 [TBL] [Abstract][Full Text] [Related]
12. Association between red blood cell distribution width and macrovascular and microvascular complications in diabetes. Malandrino N; Wu WC; Taveira TH; Whitlatch HB; Smith RJ Diabetologia; 2012 Jan; 55(1):226-35. PubMed ID: 22002006 [TBL] [Abstract][Full Text] [Related]
13. Association between serum uric acid level and microalbuminuria to chronic vascular complications in Thai patients with type 2 diabetes. Chuengsamarn S; Rattanamongkolgul S; Jirawatnotai S J Diabetes Complications; 2014; 28(2):124-9. PubMed ID: 24412514 [TBL] [Abstract][Full Text] [Related]
14. Early vascular parameters in the micro- and macrocirculation in type 2 diabetes. Kannenkeril D; Bosch A; Harazny J; Karg M; Jung S; Ott C; Schmieder RE Cardiovasc Diabetol; 2018 Sep; 17(1):128. PubMed ID: 30231923 [TBL] [Abstract][Full Text] [Related]
15. Differences in galectin-3, a biomarker of fibrosis, between participants with peripheral artery disease and participants with normal ankle-brachial index. Casanegra AI; Stoner JA; Tafur AJ; Pereira HA; Rathbun SW; Gardner AW Vasc Med; 2016 Oct; 21(5):437-444. PubMed ID: 27155290 [TBL] [Abstract][Full Text] [Related]
16. Is galectin-3 associated with urinary albumin excretion in type 2 diabetes? Yücel N; Çakır Madenci Ö; Bölük A; Köroğlu Dağdelen L; Temel Y; Sargın M; Orçun A Endokrynol Pol; 2016; 67(6):580-584. PubMed ID: 26884305 [TBL] [Abstract][Full Text] [Related]
17. [CRP and micro-albumin: new markers of cardiovascular risk in type 2 diabetes]. El Oudi M; Aouni Z; Ouertani H; Mazigh C; Nsiri B; Zidi B; Machghoul S Ann Cardiol Angeiol (Paris); 2011 Aug; 60(4):207-10. PubMed ID: 21571249 [TBL] [Abstract][Full Text] [Related]
18. Sex differences in micro- and macro-vascular complications of diabetes mellitus. Maric-Bilkan C Clin Sci (Lond); 2017 May; 131(9):833-846. PubMed ID: 28424377 [TBL] [Abstract][Full Text] [Related]
19. Increased CRP: An extended biomarker of microvascular risk in men with type 2 diabetes. Hermans MP; Ahn SA; Rousseau MF J Diabetes Complications; 2019 Nov; 33(11):107413. PubMed ID: 31477553 [TBL] [Abstract][Full Text] [Related]
20. Galectin-3 and risk of cardiovascular events and all-cause mortality in type 2 diabetes. Tan KCB; Cheung CL; Lee ACH; Lam JKY; Wong Y; Shiu SWM Diabetes Metab Res Rev; 2019 Feb; 35(2):e3093. PubMed ID: 30378236 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]